Medicine guide
Ruxience
500 mg/50mL · Injection, Solution
- Prescription only
- CD20-directed Cytolytic Antibody
- Active substance
- Rituximab-Pvvr
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Pfizer Laboratories Div Pfizer Inc |
|---|---|
| Active substance | Rituximab-Pvvr |
| Strength | 500 mg/50mL |
| Form | Injection, Solution |
| Route | Intravenous |
| Packs | 1 VIAL, SINGLE-USE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-USE |
| NDC | 0069-0249 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Solution2 products
- 100 mg/10mL
- 500 mg/50mL
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.